Compound Detail
CHEMBL2
PRAZOSIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL2 |
| Name | PRAZOSIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IENZQIKPVFGBNW-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
46
Targets
286
Activities
4
Assay Types
28
PK Parameters
20
Publications
4
Known Names
10
Indications
Molecular Properties
383.4
MW (Da)
1.78
ALogP
8
HBA
1
HBD
107.0
PSA (Ų)
0.73
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1976 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Hypertension Alcoholism Kidney Calculi Stress Disorders, Post-Traumatic Amphetamine-Related Disorders Severe Acute Respiratory Syndrome Tobacco Use Disorder Anxiety Substance Withdrawal Syndrome Urinary Bladder, Neurogenic
ATC Classification
C02CA01
prazosin
Level 1: CARDIOVASCULAR SYSTEM
Level 2: ANTIHYPERTENSIVES
Activity Summary
Ki 174 meas. best 10.57
IC50 63 meas. best 9.79
Kd 47 meas. best 10.99
EC50 2 meas. best 4.92
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adrenergic receptor alpha-1 CHEMBL1907610 | Kd | 10.99 | 8.8259 | 0.0 | 17 |
| Alpha-1B adrenergic receptor CHEMBL232 | Ki | 10.57 | 9.3989 | 0.0 | 18 |
| Alpha-1A adrenergic receptor CHEMBL229 | Ki | 10.4 | 9.4271 | 0.0 | 21 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Ki | 10.27 | 10.235 | 0.1 | 2 |
| Unchecked CHEMBL612545 | Ki | 10.15 | 9.1367 | 0.1 | 6 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 10.15 | 9.5614 | 0.1 | 7 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 10.01 | 9.5789 | 0.1 | 28 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 10.0 | 9.59 | 0.1 | 7 |
| Alpha-1A adrenergic receptor CHEMBL4892 | Ki | 9.9 | 9.46 | 0.1 | 4 |
| Alpha-1A adrenergic receptor CHEMBL319 | Kd | 9.81 | 8.9975 | 0.2 | 4 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 9.79 | 9.323 | 0.2 | 10 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 9.77 | 9.5494 | 0.2 | 17 |
| Alpha-1D adrenergic receptor CHEMBL326 | Kd | 9.77 | 9.06 | 0.2 | 5 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | IC50 | 9.77 | 9.408 | 0.2 | 5 |
| Alpha-1B adrenergic receptor CHEMBL315 | IC50 | 9.75 | 9.4633 | 0.2 | 3 |
| Alpha-1D adrenergic receptor CHEMBL326 | Ki | 9.7 | 9.295 | 0.2 | 4 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 9.66 | 9.41 | 0.2 | 2 |
| 5-hydroxytryptamine receptor 1D CHEMBL1983 | Ki | 9.48 | 9.48 | 0.3 | 1 |
| Beta-casein CHEMBL2210 | Ki | 9.44 | 9.44 | 0.4 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Kd | 9.42 | 8.916 | 0.4 | 5 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Ki | 9.4 | 6.2513 | 0.4 | 23 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 9.18 | 9.12 | 0.7 | 2 |
| Unchecked CHEMBL612545 | IC50 | 9.17 | 6.81 | 0.7 | 7 |
| Alpha-1B adrenergic receptor CHEMBL3122 | Ki | 9.08 | 9.08 | 0.8 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | Kd | 9.01 | 8.9967 | 1.0 | 3 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Kd | 8.96 | 6.1722 | 1.1 | 9 |
| Alpha-1A adrenergic receptor CHEMBL229 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL3637 | Kd | 8.3 | 8.3 | 5.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 8.26 | 8.26 | 5.5 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] CHEMBL3959 | IC50 | 8.11 | 8.11 | 7.8 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | IC50 | 8.1 | 6.5625 | 8.0 | 4 |
| Alpha-1B adrenergic receptor CHEMBL232 | IC50 | 8.06 | 8.06 | 8.7 | 1 |
| Adrenergic receptor alpha CHEMBL2095203 | Kd | 8.0 | 8.0 | 10.0 | 1 |
| Rattus norvegicus CHEMBL376 | Kd | 8.0 | 8.0 | 10.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 7.89 | 7.07 | 13.0 | 3 |
| Alpha-2 adrenergic receptor CHEMBL2111338 | Ki | 7.89 | 6.8567 | 13.0 | 3 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 7.62 | 7.2233 | 24.0 | 3 |
| Adrenergic receptor alpha-2 CHEMBL2095158 | Ki | 7.47 | 6.44 | 34.0 | 11 |
| Alpha-2A adrenergic receptor CHEMBL4744 | Ki | 6.97 | 6.97 | 106.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 6.68 | 6.1167 | 210.0 | 3 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 6.54 | 6.54 | 290.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 6.19 | 6.19 | 647.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | Ki | 5.82 | 5.82 | 1500.0 | 1 |
| Multidrug and toxin extrusion protein 1 CHEMBL1743126 | IC50 | 5.8 | 5.8 | 1600.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.8 | 5.4067 | 1584.9 | 3 |
| Alpha-2A adrenergic receptor CHEMBL327 | Ki | 5.78 | 5.78 | 1668.0 | 1 |
| Solute carrier family 22 member 1 CHEMBL5685 | IC50 | 5.74 | 5.37 | 1840.0 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 5.63 | 5.63 | 2344.2 | 2 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 5.58 | 5.58 | 2621.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 5.58 | 5.58 | 2638.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.37 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 12.02 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| F | 79.0 | % | Homo sapiens |
| F | 68.0 | % | Homo sapiens |
| Fu | 0.06 | - | Homo sapiens |
| Fu | 0.06 | - | Homo sapiens |
| Fu | 0.1 | - | Homo sapiens |
| Fu | 0.053 | - | Homo sapiens |
| Fu | 0.37 | - | Canis lupus familiaris |
| Fu | 0.35 | - | Rattus norvegicus |
| Fu | 0.0797 | - | Rattus norvegicus |
| Fu | 0.294 | - | Rattus norvegicus |
| Fu | 0.195 | - | Rattus norvegicus |
| Fu | 0.104 | - | Rattus norvegicus |
| Fu | 0.034 | - | Rattus norvegicus |
| Fu | 0.052 | - | Rattus norvegicus |
| Fu | 0.264 | - | Rattus norvegicus |
| Fu | 0.163 | - | Rattus norvegicus |
| Ke | 1.1 | nM | Homo sapiens |
| Ke | 1.1 | nM | Homo sapiens |
| MRT | 2.6 | hr | Homo sapiens |
| T1/2 | 2.8 | hr | Homo sapiens |
| T1/2 | 2.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine